Mercado Global de Jarabe para la Tos | Tamaño de la Industria, Participación, Crecimiento, Informe, Análisis 2026-2035

Por Tipo de Producto (Expectorantes, Supresores de la Tos, Medicamentos Combinados); Por Tipo de Población (Pediátrico, Adulto); Por Canal de Distribución (Farmacia Hospitalaria, Farmacia Minorista, Farmacia En Línea, Canal Público); Análisis Regional; Panorama Competitivo; 2026-2035


Última Actualización:
Autor:
Udeesha Tomar
Formato:
PDF · Excel · PPT
Páginas del Informe:
200+

USD 6.458,44 Millones

Tamaño del Mercado en 2025

3,80%

CAGR

USD 9.377,80 Millones

Pronóstico del Mercado para 2035


Comprar Ahora

Tabla de Contenidos

Language of the Report – English

Sin embargo, el informe puede estar disponible en español por un costo adicional.


1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions 
    1.3    Report Coverage – Key Segmentation and Scope  
    1.4    Research Methodology
2    Executive Summary
3    Global Cough Syrup Market Overview 

    3.1    Global Cough Syrup Market Historical Value (2019-2025) 
    3.2    Global Cough Syrup Market Forecast Value (2026-2035)
4    Global Cough Syrup Market Landscape
    4.1    Global Cough Syrup Developers Landscape
        4.1.1    Analysis by Year of Establishment
        4.1.2    Analysis by Company Size
        4.1.3    Analysis by Region
    4.2    Global Cough Syrup Product Landscape
        4.2.1    Analysis by Product Type
        4.2.2    Analysis by Drug Type 
        4.2.3    Analysis by Population type
        4.2.4    Analysis by Therapy Type
        4.2.5    Analysis by Distribution Channel
5    Global Cough Syrup Market Dynamics
    5.1    Market Drivers and Constraints
    5.2    SWOT Analysis
    5.3    Porter’s Five Forces Model 
    5.4    Key Demand Indicators
    5.5    Key Price Indicators
    5.6    Industry Events, Initiatives, and Trends 
    5.7    Value Chain Analysis
6    Global Cough Syrup Market Segmentation
    6.1    Global Cough Syrup Market by Product Type
        6.1.1    Market Overview
        6.1.2    Expectorants
        6.1.3    Cough Suppressants
        6.1.4    Combination Medications
        6.1.5    Others
    6.2    Global Cough Syrup Market by Population Type
        6.2.1    Market Overview
        6.2.2    Pediatric
        6.2.3    Adults
    6.3    Global Cough Syrup Market by Distribution Channel
        6.3.1    Market Overview
        6.3.2    Hospital Pharmacy
        6.3.3    Retail Pharmacy
        6.3.4    Online Channel
        6.3.5    Public Channel
    6.4    Global Cough Syrup Market by Region
        6.4.1    Market Overview
        6.4.2    North America 
        6.4.3    Europe
        6.4.4    Asia Pacific
        6.4.5    Latin America
        6.4.6    Middle East and Africa
7    North America Cough Syrup Market
    7.1    Market Share by Country
    7.2    United States of America
    7.3    Canada
8    Europe Cough Syrup Market
    8.1    Market Share by Country
    8.2    United Kingdom
    8.3    Germany
    8.4    France
    8.5    Italy
    8.6    Others
9    Asia Pacific Cough Syrup Market
    9.1    Market Share by Country
    9.2    China
    9.3    Japan
    9.4    India
    9.5    ASEAN
    9.6    Australia
    9.7    Others
10    Latin America Cough Syrup Market
    10.1    Market Share by Country
    10.2    Brazil
    10.3    Argentina
    10.4    Mexico
    10.5    Others
11    Middle East and Africa Cough Syrup Market
    11.1    Market Share by Country
    11.2    Saudi Arabia
    11.3    United Arab Emirates
    11.4    Nigeria
    11.5    South Africa
    11.6    Others
12    Patent Analysis
    12.1    Analysis by Type of Patent
    12.2    Analysis by Publication Year
    12.3    Analysis by Issuing Authority
    12.4    Analysis by Patent Age
    12.5    Analysis by CPC Analysis
    12.6    Analysis by Patent Valuation 
    12.7    Analysis by Key Players
13    Grants Analysis
    13.1    Analysis by year
    13.2    Analysis by Amount Awarded
    13.3    Analysis by Issuing Authority
    13.4    Analysis by Grant Application
    13.5    Analysis by Funding Institute
    13.6    Analysis by NIH Departments
    13.7    Analysis by Recipient Organization 
14    Funding Analysis
    14.1    Analysis by Funding Instances
    14.2    Analysis by Type of Funding
    14.3    Analysis by Funding Amount
    14.4    Analysis by Leading Players
    14.5    Analysis by Leading Investors
    14.6    Analysis by Geography
15    Partnership and Collaborations Analysis
    15.1    Analysis by Partnership Instances
    15.2    Analysis by Type of Partnership
    15.3    Analysis by Leading Players
    15.4    Analysis by Geography
16    Regulatory Framework
    16.1    Regulatory Overview
        16.1.1    US FDA
        16.1.2    EU EMA
        16.1.3    INDIA CDSCO
        16.1.4    JAPAN PMDA
        16.1.5    Others
17    Supplier Landscape
    17.1    Acella Pharmaceuticals LLC
        17.1.1    Financial Analysis
        17.1.2    Product Portfolio
        17.1.3    Demographic Reach and Achievements
        17.1.4    Mergers and Acquisitions
        17.1.5    Certifications
    17.2    Bayer AG
        17.2.1    Financial Analysis
        17.2.2    Product Portfolio
        17.2.3    Demographic Reach and Achievements
        17.2.4    Mergers and Acquisitions
        17.2.5    Certifications
    17.3    GlaxoSmithKline PLC
        17.3.1    Financial Analysis
        17.3.2    Product Portfolio
        17.3.3    Demographic Reach and Achievements
        17.3.4    Mergers and Acquisitions
        17.3.5    Certifications
    17.4    Johnson & Johnson
        17.4.1    Financial Analysis
        17.4.2    Product Portfolio
        17.4.3    Demographic Reach and Achievements
        17.4.4    Mergers and Acquisitions
        17.4.5    Certifications
    17.5    Pfizer Inc.
        17.5.1    Financial Analysis
        17.5.2    Product Portfolio
        17.5.3    Demographic Reach and Achievements
        17.5.4    Mergers and Acquisitions
        17.5.5    Certifications
    17.6    Prestige Consumer Healthcare Inc.
        17.6.1    Financial Analysis
        17.6.2    Product Portfolio
        17.6.3    Demographic Reach and Achievements
        17.6.4    Mergers and Acquisitions
        17.6.5    Certifications
    17.7    Reckitt Benckiser Group PLC
        17.7.1    Financial Analysis
        17.7.2    Product Portfolio
        17.7.3    Demographic Reach and Achievements
        17.7.4    Mergers and Acquisitions
        17.7.5    Certifications
    17.8    Sanofi
        17.8.1    Financial Analysis
        17.8.2    Product Portfolio
        17.8.3    Demographic Reach and Achievements
        17.8.4    Mergers and Acquisitions
        17.8.5    Certifications
    17.9    Sun Pharmaceutical Industries Limited
        17.9.1    Financial Analysis
        17.9.2    Product Portfolio
        17.9.3    Demographic Reach and Achievements
        17.9.4    Mergers and Acquisitions
        17.9.5    Certifications
    17.10    The Procter & Gamble Company
        17.10.1    Financial Analysis
        17.10.2    Product Portfolio
        17.10.3    Demographic Reach and Achievements
        17.10.4    Mergers and Acquisitions
        17.10.5    Certifications
18    Global Cough Syrup Market - Distribution Model (Additional Insight)
    18.1    Overview 
    18.2    Potential Distributors 
    18.3    Key Parameters for Distribution Partner Assessment 
19    Key Opinion Leaders (KOL) Insights (Additional Insight)
20    Company Competitiveness Analysis (Additional Insight)

    20.1    Very Small Companies
    20.2    Small Companies
    20.3    Mid-Sized Companies
    20.4    Large Companies
    20.5    Very Large Companies
21    Payment Methods (Additional Insight)
    21.1    Government Funded
    21.2    Private Insurance
    21.3    Out-of-Pocket

*The list of players in the competitive landscape section can be customised or made more exhaustive based on your specific requirements.*

Contenidos